According to aInforma Connect生命科学公司最近的研究,29%许多制药行业的专业人士预测，基因疗法将是未来10年增长最快的治疗领域，并将进一步发展13%predicting cell therapies. Based on the results of an April 2020 study of 432 life sciences professionals from the pharma, biotech, medical device and regulatory industries around the world, the responses confirm the excitement surrounding the future possibilities of gene therapies.
With gene therapies out on their own, cell therapies are joined by biologics and immunotherapies with13%of the responses, with vaccines (9%), medical devices (6%)，和抗体(7%)，寡核苷酸(3%)微生物组(3%) therapeutics making up the numbers.
When comparing between regions, there is largely a consensus between those working in North America and Europe - with gene therapies coming out on top for every global region. However, there are a few notable exceptions. Just9%of European respondents believe cell therapies will see the fastest growth, versus19%of North Americans, and conversely,13%大多数欧洲人认为疫苗是最令人兴奋的治疗领域，而不仅仅是3%北美洲的。
受访者预计，这种基因疗法的繁荣将有助于推动未来十年肿瘤治疗的革命，并带来27%predicting that the biggest advances in oncology will be gene therapies, followed by immunotherapies (25%)和细胞疗法(21%).
In which of the following therapeutic areas do you think treatment will most improve in the next 10 years?
Oncology is the area that respondents are most excited about by far, with50%predicting it will be the area in which treatment will most improve in the coming decade. With huge investment and numerous promising therapeutics being developed and approved, this will surprise few.
